Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin C Schumacher

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Natural history of prostate cancer, chemoprevention and active surveillanceOla Bratt, Martin C Schumacher
BJU International|January 22, 2009
Ureteric frozen sections during radical cystectomy for transitional cell carcinoma of the bladder--to do or not to do?Martin C Schumacher, Urs E Studer
Current Opinion in Urology|October 7, 2011
Robotic-assisted reconstructive urologyMudhar N Hasan, Martin C Schumacher, Peter N Wiklund
Current Opinion in Urology|June 26, 2009
Does extended lymphadenectomy preclude laparoscopic or robot-assisted radical cystectomy in advanced bladder cancer?Martin C Schumacher, Martin N Jonsson, N Peter Wiklund
Nature Clinical Practice. Urology|September 12, 2006
An extended pelvic lymph-node dissection should be performed in most patients if radical prostatectomy is truly indicatedFiona C Burkhard, Martin C Schumacher, Urs E Studer
Scandinavian Journal of Urology|July 9, 2014
[11C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomyMartin C Schumacher, Eva Radecka, Magnus Hellström, et al.
European Urology|November 17, 2009
Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre studyMartin C Schumacher, Sten Holmäng, Thomas Davidsson, et al.
European Urology|May 31, 2008
Good outcome for patients with few lymph node metastases after radical retropubic prostatectomyMartin C Schumacher, Fiona C Burkhard, George N Thalmann, et al.
European Urology|April 25, 2006
Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer?Martin C Schumacher, Fiona C Burkhard, George N Thalmann, et al.
Urologic Oncology|March 19, 2011
A comparative study of tissue ω-6 and ω-3 polyunsaturated fatty acids (PUFA) in benign and malignant pathologic stage pT2a radical prostatectomy specimensMartin C Schumacher, Brett Laven, Fredrik Petersson, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Natural history of prostate cancer, chemoprevention and active surveillanceOla Bratt, Martin C Schumacher
BJU International|January 22, 2009
Ureteric frozen sections during radical cystectomy for transitional cell carcinoma of the bladder--to do or not to do?Martin C Schumacher, Urs E Studer
Current Opinion in Urology|October 7, 2011
Robotic-assisted reconstructive urologyMudhar N Hasan, Martin C Schumacher, Peter N Wiklund
Current Opinion in Urology|June 26, 2009
Does extended lymphadenectomy preclude laparoscopic or robot-assisted radical cystectomy in advanced bladder cancer?Martin C Schumacher, Martin N Jonsson, N Peter Wiklund
Nature Clinical Practice. Urology|September 12, 2006
An extended pelvic lymph-node dissection should be performed in most patients if radical prostatectomy is truly indicatedFiona C Burkhard, Martin C Schumacher, Urs E Studer
Scandinavian Journal of Urology|July 9, 2014
[11C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomyMartin C Schumacher, Eva Radecka, Magnus Hellström, et al.
European Urology|November 17, 2009
Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre studyMartin C Schumacher, Sten Holmäng, Thomas Davidsson, et al.
European Urology|May 31, 2008
Good outcome for patients with few lymph node metastases after radical retropubic prostatectomyMartin C Schumacher, Fiona C Burkhard, George N Thalmann, et al.
European Urology|April 25, 2006
Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer?Martin C Schumacher, Fiona C Burkhard, George N Thalmann, et al.
Urologic Oncology|March 19, 2011
A comparative study of tissue ω-6 and ω-3 polyunsaturated fatty acids (PUFA) in benign and malignant pathologic stage pT2a radical prostatectomy specimensMartin C Schumacher, Brett Laven, Fredrik Petersson, et al.
Pageof 3